Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.48% | 160.69 | 0.7% | $1221.58m | |
| PFE | Pfizer Inc. | 1.17% | 37.61 | 0.9% | $1016.38m | |
| MRK | Merck & Co., Inc. | 0.35% | 76.67 | 0.7% | $965.72m | |
| ABBV | AbbVie, Inc. | 0.94% | 106.90 | 1.9% | $828.02m | |
| BMY | Bristol-Myers Squibb Co. | 1.00% | 64.45 | 1.0% | $731.74m | |
| LLY | Eli Lilly & Co. | 1.65% | 186.01 | 1.1% | $577.53m | |
| AZN | AstraZeneca Plc | 1.99% | 50.83 | 1.2% | $442.51m | |
| GSK | GlaxoSmithKline Plc | 4.26% | 37.67 | 0.2% | $213.98m | |
| RPRX | Royalty Pharma Plc | -1.12% | 41.65 | 0.2% | $157.73m | |
| NVS | Novartis AG | 0.52% | 87.20 | 0.2% | $153.46m | |
| VTRS | Viatris, Inc. | 0.53% | 13.28 | 0.0% | $128.16m | |
| RGEN | Repligen Corp. | 4.03% | 213.57 | 6.8% | $89.09m | |
| CVAC | CureVac NV | 1.40% | 104.05 | 0.0% | $87.46m | |
| SNY | Sanofi | 0.90% | 50.69 | 0.2% | $60.91m | |
| ATNF | 180 Life Sciences Corp. | -4.02% | 10.04 | 0.0% | $60.80m |
Company Profile
AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.